These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7667389)

  • 41. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
    Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
    Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).
    Olianas MC; Maullu C; Adem A; Mulugeta E; Karlsson E; Onali P
    Br J Pharmacol; 2000 Oct; 131(3):447-52. PubMed ID: 11015294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The interaction of 4-DAMP mustard with subtypes of the muscarinic receptor.
    Ehlert FJ
    Life Sci; 1996; 58(22):1971-8. PubMed ID: 8637426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chimeric m2/m3 muscarinic receptors: role of carboxyl terminal receptor domains in selectivity of ligand binding and coupling to phosphoinositide hydrolysis.
    Wess J; Bonner TI; Brann MR
    Mol Pharmacol; 1990 Dec; 38(6):872-7. PubMed ID: 2174507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
    Pei XF; Gupta TH; Badio B; Padgett WL; Daly JW
    J Med Chem; 1998 Jun; 41(12):2047-55. PubMed ID: 9622546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selectivity of class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide for peripheral muscarinic M2 and M3 receptors.
    Endou M; Hattori Y; Gando S; Kanno M
    J Cardiovasc Pharmacol; 1992 May; 19(5):674-81. PubMed ID: 1381764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of muscarinic acetylcholine receptors via their allosteric binding sites.
    Jakubík J; Bacáková L; Lisá V; el-Fakahany EE; Tucek S
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8705-9. PubMed ID: 8710935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.
    Jakubík J; Randáková A; El-Fakahany EE; Dolezal V
    BMC Pharmacol; 2009 Dec; 9():15. PubMed ID: 20038295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mixed competitive and allosteric antagonism by gallamine of muscarinic receptor-mediated second messenger responses in N1E-115 neuroblastoma cells.
    Lee NH; el-Fakahany EE
    J Neurochem; 1989 Oct; 53(4):1300-8. PubMed ID: 2549200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dual effects of muscarinic M(2) acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists.
    Michal P; Lysíková M; Tucek S
    Br J Pharmacol; 2001 Mar; 132(6):1217-28. PubMed ID: 11250872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.
    Salmon M; Luttmann MA; Foley JJ; Buckley PT; Schmidt DB; Burman M; Webb EF; DeHaas CJ; Kotzer CJ; Barrett VJ; Slack RJ; Sarau HM; Palovich MR; Lainé DI; Hay DW; Rumsey WL
    J Pharmacol Exp Ther; 2013 May; 345(2):260-70. PubMed ID: 23435542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vinburnine decelerates [3H]N-methylscopolamine binding to recombinant human muscarinic M1-M4 acetylcholine receptors.
    Maksay G; Bíró T; Kiss B
    Eur J Pharmacol; 2004 Jan; 483(2-3):229-32. PubMed ID: 14729111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors.
    Cembala TM; Forde SC; Appadu BL; Lambert DG
    Eur J Pharmacol; 2007 Aug; 569(1-2):37-40. PubMed ID: 17588565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p-Fluoro-hexahydro-sila-difenidol exhibits poor selectivity between M3 and M1 muscarinic receptors.
    Meng Y; Hu J; el-Fakahany EE
    Membr Biochem; 1990; 9(4):293-300. PubMed ID: 1967074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterisation of [3H]-darifenacin as a novel radioligand for the study of muscarinic M3 receptors.
    Smith CM; Wallis RM
    J Recept Signal Transduct Res; 1997; 17(1-3):177-84. PubMed ID: 9029489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
    Buckley NJ; Bonner TI; Buckley CM; Brann MR
    Mol Pharmacol; 1989 Apr; 35(4):469-76. PubMed ID: 2704370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
    Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for cross-talk between M2 and M3 muscarinic acetylcholine receptors in the regulation of second messenger and extracellular signal-regulated kinase signalling pathways in Chinese hamster ovary cells.
    Hornigold DC; Mistry R; Raymond PD; Blank JL; Challiss RA
    Br J Pharmacol; 2003 Apr; 138(7):1340-50. PubMed ID: 12711635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, molecular modeling studies, and muscarinic receptor activity of azaprophen analogues.
    Triggle DJ; Kwon YW; Abraham P; Pitner JB; Mascarella SW; Carroll FI
    J Med Chem; 1991 Nov; 34(11):3164-71. PubMed ID: 1956033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
    Böhme TM; Keim C; Kreutzmann K; Linder M; Dingermann T; Dannhardt G; Mutschler E; Lambrecht G
    J Med Chem; 2003 Feb; 46(5):856-67. PubMed ID: 12593665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.